Maximus Inc (NYSE: MMS) shares fell -0.50% to end trading Tuesday at $92.14 per share - a net change of $-0.46. Shares traded between $92.73 and $91.64 throughout the day.

323397 shares of Maximus Inc exchanged hands.

Visit Maximus Inc’s profile for more information.

About The New York Stock Exchange

The New York Stock Exchange is the world’s largest stock exchange by market value at over $26 trillion. It is also the leader for initial public offerings, with $82 billion raised in 2020, including six of the seven largest technology deals. 63% of SPAC proceeds in 2020 were raised on the NYSE, including the six largest transactions.

To get more information on Maximus Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Maximus Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by Barchart as of 4:30pm ET on the day of publication.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

Stocks To Watch in 5G Wireless Growth Wave: Jeff Kagan

Betting Against Elon Musk Has Not Been Profitable

Five Fallen Biotech Stocks We're Watching for Rebounds

Innate Pharma Gets $50 Million From AstraZeneca as Monalizumab Phase 3 Lung Cancer Trial Begins

Cohere Technologies Focused on 5G Fixed Wireless Access: Jeff Kagan

Arizona Sonoran Copper Raises C$35 Million, Including Strategic Investment by Rio Tinto

Market Stages Strong Thursday Rally, Though April Still on Pace To Be Worst Month in Two Years

Cytovia Therapeutics To Go Public Via $600 Million SPAC Merger